 0 Table of Contents |
  1 Home |
  2 Downloads |
  3 Logical Models |
  4 Authors and contributors |
  5 Obligations |
  6 Known Issues |
  7 Scope and content |
  8 Background |
  9 Challenges |
  10 Design Approach |
  11 References |
  12 Model Map Overview |
  13 Dependencies |
  14 Change Log |
  15 Copyright |
  16 Cross version analysis |
  17 Expansion Parameters |
  18 EHDSDischargeReport Mapping |
  19 EHDSAttachment Mapping |
  20 EHDSCarePlan Mapping |
  21 EHDSDeviceUse Mapping |
  22 EHDSDevice Mapping |
  23 EHDSLaboratoryObservation Mapping |
  24 EHDSRelatedPerson Mapping |
  25 EHDSEncounter Mapping |
  26 Artifacts Summary |
   26.1 Bundle: obligations |
   26.2 Composition: obligations |
   26.3 AllergyIntolerance: obligations |
   26.4 CarePlan: obligations |
   26.5 Condition: obligations |
   26.6 Device: obligations |
   26.7 DeviceUseStatement: obligations |
   26.8 Encounter: obligations |
   26.9 Flag: obligations |
   26.10 Immunization: obligations |
   26.11 Medication: obligations |
   26.12 MedicationAdministration: obligations |
   26.13 MedicationDispense: obligations |
   26.14 MedicationRequest: obligations |
   26.15 MedicationStatement: obligations |
   26.16 Observation (laboratory): obligations |
   26.17 Observation: obligations |
   26.18 Organization: obligations |
   26.19 Patient: obligations |
   26.20 Practitioner: obligations |
   26.21 PractitionerRole: obligations |
   26.22 Procedure: obligations |
   26.23 RelatedPerson: obligations |
   26.24 Specimen: obligations |
   26.25 Bundle (HDR) |
   26.26 CarePlan (HDR) |
   26.27 Composition (HDR) |
   26.28 Device (HDR) |
   26.29 DeviceUseStatement (HDR) |
   26.30 Encounter (HDR) |
   26.31 Goal (HDR) |
   26.32 MedicationAdministration (HDR) |
   26.33 MedicationDispense (HDR) |
   26.34 Admission Urgency Value Set |
   26.35 Condition Value Set (HDR) |
   26.36 Encounter Class Value Set |
   26.37 Encounter Status Value Set |
   26.38 Encounter Type Value Set |
   26.39 AllergyIntolerance: Critical Allergy to Penicillin |
   26.40 BodyStructure: Left Hip Joint |
   26.41 Bundle: HDR Acute Respiratory Failure (Italian) |
   26.42 Bundle: HDR Inguinal Hernia with Sub-sections (Czech) |
   26.43 Bundle: HDR Lower Leg Fracture |
   26.44 Bundle: HDR Twin Delivery by Cesarean Section |
   26.45 Bundle: HDR Type 2 Diabetes Mellitus |
   26.46 CarePlan: Diabetes Management Plan |
   26.47 Composition: HDR Type 2 Diabetes Mellitus |
   26.48 Condition: Osteoarthritis of the Left Hip |
   26.49 Condition: Type 2 Diabetes Mellitus |
   26.50 Device: Implantable Pacemaker |
   26.51 Device: Total Hip Replacement Prosthesis |
   26.52 DeviceUseStatement: Implanted Pacemaker |
   26.53 DeviceUseStatement: Total Hip Replacement Prosthesis |
   26.54 Encounter: Hospital admission and discharge, Reijer Wolff |
   26.55 FamilyMemberHistory: Type 2 Diabetes Mellitus - Mother |
   26.56 Flag: Critical Allergy to Penicillin |
   26.57 Flag: Do Not Use Left Arm |
   26.58 Goal: Postoperative Mobilization |
   26.59 Immunization: COVID-19 vaccine dose administered |
   26.60 Medication: Cefuroxime 1500 mg, branded |
   26.61 Medication: Cefuroxime 1500 mg, generic |
   26.62 MedicationAdministration: Paracetamol |
   26.63 MedicationDispense: Cefuroxime 1500 mg, First Dispense |
   26.64 MedicationRequest: Cefuroxime 1500 mg, Single Line |
   26.65 MedicationStatement: Enalapril |
   26.66 Observation: Abdominal circumference |
   26.67 Observation: ABO Group |
   26.68 Observation: Alcohol use |
   26.69 Observation: Blood pressure |
   26.70 Observation: Body height |
   26.71 Observation: Body mass index |
   26.72 Observation: Body weight, Fiona Swart |
   26.73 Observation: Body weight, Petr Novák |
   26.74 Observation: Chest circumference |
   26.75 Observation: Head circumference |
   26.76 Observation: Smoking status |
   26.77 Organization: Erasmus MC |
   26.78 Patient: Dutch Patient |
   26.79 Procedure: Cesarean Section |
   26.80 Procedure: Total Replacement of the Left Hip |